Bioequivalence of Amphotericin B Liposome for Injection
Clinical trial NCT05913921 · COMPLETED
Trial details
- NCT number
- NCT05913921
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-02
- Primary completion
- 2023-09-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.